|
38 Companies |
|
50 Products |
|
50 Products |
|
51 Mechanisms of Action |
|
3 Trials |
|
1810 News |
|
| «12...678910111213141516...3132» |
- || Chantix (varenicline) / Pfizer
Trial primary completion date: Effect of Varenicline on Fixed-Dose Alcohol Administration in Participants With Alcohol Use Disorders (clinicaltrials.gov) - Apr 14, 2015
P2, N=60, Active, not recruiting, Sponsor: Yale University
Trial primary completion date: Aug 2015 --> Aug 2016
- || Chantix (varenicline) / Pfizer
Trial primary completion date: The Effect of Naltrexone and Varenicline on Alcohol-Mediated Smoking Lapse (clinicaltrials.gov) - Apr 14, 2015
P2, N=60, Active, not recruiting, Sponsor: Yale University
Trial primary completion date: Aug 2015 --> Aug 2016 Trial primary completion date: Sep 2015 --> Sep 2016
- || Chantix (varenicline) / Pfizer
Trial primary completion date: Do Treatments for Smoking Cessation Affect Alcohol Drinking? (clinicaltrials.gov) - Apr 14, 2015
P2, N=308, Active, not recruiting, Sponsor: Yale University
Trial primary completion date: Sep 2015 --> Sep 2016 Trial primary completion date: Dec 2015 --> Dec 2016
- ||| doxazosin mesylate / Generic mfg.
Enrollment closed: Does Doxazosin Attenuate Stress-induced Smoking and Improve Clinical Outcomes? (clinicaltrials.gov) - Apr 14, 2015
P2, N=60, Active, not recruiting, Sponsor: Yale University
Trial primary completion date: Dec 2015 --> Dec 2016 Recruiting --> Active, not recruiting
- Trial completion: Technological Innovations in Behavioral Treatments for Cigarette Smoking (clinicaltrials.gov) - Apr 14, 2015
P=N/A, N=96, Completed, Sponsor: National Development and Research Institutes, Inc.
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | Trial completion: Does Moderate Intensity Exercise Help Prevent Smoking Relapse Among Women? (clinicaltrials.gov) - Apr 14, 2015
P2/3, N=59, Completed, Sponsor: The Miriam Hospital
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment open, Trial primary completion date: Kids Safe and Smokefree (KiSS) (clinicaltrials.gov) - Apr 13, 2015
P=N/A, N=325, Recruiting, Sponsor: Temple University
Active, not recruiting --> Completed Active, not recruiting --> Recruiting | Trial primary completion date: Feb 2016 --> Jun 2016
- Enrollment closed, Trial primary completion date: Vigorous Exercise for Depressed Smokers (clinicaltrials.gov) - Apr 10, 2015
P=N/A, N=40, Active, not recruiting, Sponsor: Mayo Clinic
Active, not recruiting --> Recruiting | Trial primary completion date: Feb 2016 --> Jun 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Dec 2015
- Trial completion: Phone-Based Postpartum Continuing Care for Smoking Cessation (clinicaltrials.gov) - Apr 10, 2015
P1/2, N=130, Completed, Sponsor: Battelle Memorial Institute
Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Dec 2015 Active, not recruiting --> Completed
- Chantix (varenicline) / Pfizer
Enrollment change: VarenSmoke: Study of Varencline Effects on Cigarette Smoking Reward and Craving During a Model of Brief Quit Attempt (clinicaltrials.gov) - Apr 9, 2015
P1/2, N=0, Withdrawn, Sponsor: New York University School of Medicine
Active, not recruiting --> Completed N=40 --> 0
- Enrollment closed, Trial initiation date, Trial primary completion date: GESTABAC: Effectiveness of an Intervention in Primary Care to Promote Smoking Cessation in Pregnant Women (clinicaltrials.gov) - Apr 9, 2015
P=N/A, N=600, Active, not recruiting, Sponsor: Gerencia de Atenci
N=40 --> 0 Not yet recruiting --> Active, not recruiting | Initiation date: Jun 2013 --> Dec 2013 | Trial primary completion date: Dec 2013 --> Dec 2014
- Chantix (varenicline) / Pfizer
Trial completion, Real-world evidence, Real-world: Reducing Cardiovascular Disease by Combining Smoking Cessation Pharmacotherapy and Behavioural Counseling (clinicaltrials.gov) - Apr 9, 2015
P4, N=1068, Completed, Sponsor: Ottawa Heart Institute Research Corporation
Not yet recruiting --> Active, not recruiting | Initiation date: Jun 2013 --> Dec 2013 | Trial primary completion date: Dec 2013 --> Dec 2014 Active, not recruiting --> Completed
- Trial completion: DARSSA: Dynamic Assessment and Referral System - Evaluation (clinicaltrials.gov) - Apr 9, 2015
P2, N=758, Completed, Sponsor: University of Massachusetts, Worcester
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment change, Trial termination: Assessment of Early Genetic Changes in Smokers (clinicaltrials.gov) - Apr 8, 2015
P=N/A, N=10, Terminated, Sponsor: Montefiore Medical Center
Active, not recruiting --> Completed N=140 --> 10 | Withdrawn --> Terminated; unable to obtain funding
- | Chantix (varenicline) / Pfizer
Enrollment closed: Evaluation of Varenicline (Champix) in Smoking Cessation for Patients Post-Acute Coronary Syndrome (EVITA) Trial (clinicaltrials.gov) - Apr 8, 2015
P3, N=300, Active, not recruiting, Sponsor: Mark Eisenberg
N=140 --> 10 | Withdrawn --> Terminated; unable to obtain funding Recruiting --> Active, not recruiting
- Enrollment closed: PACES: Post Acute Coronary Event Smoking Study (clinicaltrials.gov) - Apr 7, 2015
P=N/A, N=72, Active, not recruiting, Sponsor: The Miriam Hospital
Recruiting --> Active, not recruiting Enrolling by invitation --> Active, not recruiting
- | NN1213 / Novo Nordisk
Trial completion: Facilitating Implementation of the PHS Smoking Cessation Guidelines - RESET (clinicaltrials.gov) - Apr 5, 2015
P=N/A, N=1900, Completed, Sponsor: Department of Veterans Affairs
Enrolling by invitation --> Active, not recruiting No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: A Randomized Trial to Implement the AHCPR Smoking Cessation Guideline (clinicaltrials.gov) - Apr 5, 2015
P4, N=4000, Completed, Sponsor: Department of Veterans Affairs
No longer recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Implementing Guidelines for Smoking Cessation: A Randomized Trial of Evidence-Based Quality Improvement (clinicaltrials.gov) - Apr 5, 2015
P=N/A, N=2500, Completed, Sponsor: Department of Veterans Affairs
Active, not recruiting --> Completed No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Centralized Telephone Outreach to Assist Smoking Cessation Among Veterans (clinicaltrials.gov) - Apr 5, 2015
P4, N=800, Completed, Sponsor: Department of Veterans Affairs
No longer recruiting --> Completed Recruiting --> Completed
- ||| Trial completion, Trial primary completion date: Technology-Enhanced Quitline Services to Prevent Smoking Relapse (clinicaltrials.gov) - Apr 3, 2015
P=N/A, N=1785, Completed, Sponsor: Indiana University
Recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Jan 2015 --> Jan 2013
- ||| Trial completion, Enrollment change: Enhancing a High School Based Smoking Cessation Program (clinicaltrials.gov) - Apr 1, 2015
P=N/A, N=169, Completed, Sponsor: Yale University
Active, not recruiting --> Completed | Trial primary completion date: Jan 2015 --> Jan 2013 Active, not recruiting --> Completed | N=240 --> 169
- Trial completion: Evaluation of Environmental Emissions From Electronic Cigarettes and Tobacco-Burning Cigarettes (clinicaltrials.gov) - Mar 26, 2015
P=N/A, N=71, Completed, Sponsor: R.J. Reynolds Vapor Company
Active, not recruiting --> Completed | N=240 --> 169 Active, not recruiting --> Completed
- Enrollment closed: Web and Phone Intervention to Maintain Postpartum Tobacco Abstinence (clinicaltrials.gov) - Mar 24, 2015
P=N/A, N=100, Active, not recruiting, Sponsor: Oregon Research Institute
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Enrollment closed, Trial primary completion date, Adherence: Improving Adherence to Web-Based Cessation Programs: A Social Network Approach (clinicaltrials.gov) - Mar 24, 2015
P=N/A, N=5292, Active, not recruiting, Sponsor: American Legacy Foundation
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2015 --> Oct 2015
- Trial completion: Study of the Diffusion of a Smoking Cessation Application Through an Online Network (clinicaltrials.gov) - Mar 24, 2015
P=N/A, N=11413, Completed, Sponsor: American Legacy Foundation
Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2015 --> Oct 2015 Active, not recruiting --> Completed
- | Trial completion: Smoking Cessation for Veterans With Severe and Persistent Mental Illness (clinicaltrials.gov) - Mar 20, 2015
P2/3, N=179, Completed, Sponsor: Department of Veterans Affairs
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Development of Positive Psychotherapy for Smoking Cessation (clinicaltrials.gov) - Mar 19, 2015
P2, N=66, Completed, Sponsor: Brown University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||| Trial completion: Identifying Optimal Smoking Cessation Intervention Components (Cessation) (clinicaltrials.gov) - Mar 17, 2015
P4, N=637, Completed, Sponsor: University of Wisconsin, Madison
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: TeleQuit Smoking Cessation Program (clinicaltrials.gov) - Mar 15, 2015
P=N/A, N=3120, Completed, Sponsor: Department of Veterans Affairs
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial primary completion date: Internet and Telephone Counseling for Smoking Cessation (clinicaltrials.gov) - Mar 14, 2015
P=N/A, N=2205, Active, not recruiting, Sponsor: Georgetown University
Active, not recruiting --> Completed Trial primary completion date: Oct 2009 --> Oct 2015
- |||| Chantix (varenicline) / Pfizer
Trial completion: EAGLES: Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders (clinicaltrials.gov) - Mar 12, 2015
P4, N=8000, Completed, Sponsor: Pfizer
Trial primary completion date: Oct 2009 --> Oct 2015 Active, not recruiting --> Completed
- ||| Trial completion, Enrollment change: Environments as Smoking Cues: Imaging Brain Substrates, Developing New Treatments (CameraCue) (clinicaltrials.gov) - Mar 11, 2015
P=N/A, N=67, Completed, Sponsor: Duke University
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=120 --> 67
- Trial primary completion date: Impact of Current Smoking in the Tolerance of Bronchoscopy (clinicaltrials.gov) - Mar 10, 2015
P=N/A, N=100, Terminated, Sponsor: Centre Hospitalier Universitaire Saint Pierre
Active, not recruiting --> Completed | N=120 --> 67 Trial primary completion date: Nov 2013 --> Aug 2013
- Trial primary completion date: Mechanisms of the Nicotine Metabolism Effect on Tobacco Dependence (clinicaltrials.gov) - Mar 9, 2015
P=N/A, N=320, Recruiting, Sponsor: University of California, San Francisco
Trial primary completion date: Nov 2013 --> Aug 2013 Trial primary completion date: Mar 2015 --> Jun 2015
- || Enrollment closed, Trial primary completion date, HEOR: Comparative Effectiveness of Adding Weight Control to Smoking Cessation Quitlines (clinicaltrials.gov) - Mar 9, 2015
P=N/A, N=2550, Active, not recruiting, Sponsor: Alere Wellbeing
Trial primary completion date: Mar 2015 --> Jun 2015 Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Jan 2015 --> Jan 2016
- Biomarker, Trial primary completion date: Biomarkers of Molecular Risk in Smokers (clinicaltrials.gov) - Mar 7, 2015
P=N/A, N=40, Active, not recruiting, Sponsor: Memorial Sloan Kettering Cancer Center.
Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Jan 2015 --> Jan 2016 Trial primary completion date: Feb 2015 --> Feb 2016
- || Enrollment change: Innovative Smartphone Application of a New Behavioral Method to Quit Smoking: Pilot Trial (Smart Quit) (clinicaltrials.gov) - Mar 7, 2015
P=N/A, N=196, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Trial primary completion date: Feb 2015 --> Feb 2016 N=160 --> 196
- Trial completion, Trial primary completion date: Parent Willingness to Participate in Tobacco Trials in the Pediatric Clinical Setting (clinicaltrials.gov) - Mar 7, 2015
P=N/A, N=88, Completed, Sponsor: St. Jude Children's Research Hospital
N=160 --> 196 Active, not recruiting --> Completed | Trial primary completion date: Dec 2014 --> Jul 2014
- ||| Trial completion, Enrollment change: The Feasibility of Text Messaging to Assess Secondhand Smoke Exposure Among Youngsters With Cancer or Sickle Cell Disease (clinicaltrials.gov) - Mar 7, 2015
P=N/A, N=77, Completed, Sponsor: St. Jude Children's Research Hospital
Active, not recruiting --> Completed | Trial primary completion date: Dec 2014 --> Jul 2014 Active, not recruiting --> Completed | N=110 --> 77
- Trial completion: PATH Partnering to Achieve Tobacco-free Health (clinicaltrials.gov) - Mar 7, 2015
P1/2, N=450, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed | N=110 --> 77 Active, not recruiting --> Completed
- | Enrollment closed, Trial primary completion date: CHANGE -it is About Life (clinicaltrials.gov) - Mar 5, 2015
P3, N=430, Active, not recruiting, Sponsor: Mental Health Services in the Capital Region, Denmark
Active, not recruiting --> Completed Not yet recruiting --> Active, not recruiting | Trial primary completion date: Aug 2016 --> May 2016
- | Enrollment change, MRI: Functional Magnetic Resonance Imaging (fMRI) Investigation of Nicotine Withdrawal Symptoms (clinicaltrials.gov) - Mar 2, 2015
P4, N=23, Completed, Sponsor: GlaxoSmithKline
Not yet recruiting --> Active, not recruiting | Trial primary completion date: Aug 2016 --> May 2016 N=30 --> 23
- Trial primary completion date: Acceptance and Commitment Therapy for Smoking Cessation in the Primary Care Setting (clinicaltrials.gov) - Feb 24, 2015
P=N/A, N=156, Recruiting, Sponsor: The Hong Kong Polytechnic University
N=30 --> 23 Trial primary completion date: Sep 2013 --> Apr 2015
- naltrexone / Generic mfg.
Trial primary completion date: Naltrexone for At-Risk and Problem Drinking in Smoking Cessation Treatment (clinicaltrials.gov) - Feb 24, 2015
P2, N=300, Recruiting, Sponsor: Brown University
Trial primary completion date: Sep 2013 --> Apr 2015 Trial primary completion date: Apr 2015 --> Oct 2015
- |||| erlotinib / Generic mfg.
Trial primary completion date, Metastases: A Study of Tarceva (Erlotinib) to Compare Two Different Doses in in Currently Smoking Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (CURRENTS) (clinicaltrials.gov) - Feb 23, 2015
P3, N=315, Completed, Sponsor: Hoffmann-La Roche
Trial primary completion date: Apr 2015 --> Oct 2015 Trial primary completion date: Feb 2014 --> Oct 2013
- ||| Chantix (varenicline) / Pfizer
Enrollment closed: EAGLES: Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders (clinicaltrials.gov) - Feb 19, 2015
P4, N=8000, Active, not recruiting, Sponsor: Pfizer
Trial primary completion date: Feb 2014 --> Oct 2013 Recruiting --> Active, not recruiting
- |||| Trial completion, Adherence: Evaluation of Treatments to Improve Smoking Cessation Medication Adherence (clinicaltrials.gov) - Feb 19, 2015
P4, N=544, Completed, Sponsor: University of Wisconsin, Madison
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Trial completion, Phase classification: MTS: Trial on the Effectiveness of Mindfulness Training for Smokers (clinicaltrials.gov) - Feb 19, 2015
P=N/A, N=196, Completed, Sponsor: Stevens S. Smith, Ph.D.
Active, not recruiting --> Completed Active, not recruiting --> Completed | Phase classification: P1/2 --> PN/A
- || Trial primary completion date: Genetics of Peripheral Artery Genomics (clinicaltrials.gov) - Feb 12, 2015
P=N/A, N=100, Recruiting, Sponsor: Duke University
Active, not recruiting --> Completed | Phase classification: P1/2 --> PN/A Trial primary completion date: Dec 2014 --> Dec 2015